Source link : https://newshealth.biz/health-news/novel-drug-shrinks-73-of-her2-mutant-lung-cancers/
(MedPage Today) — An investigational antibody-drug conjugate proved active and safe for patients with previously treated HER2-mutant non-small cell lung cancer (NSCLC), a phase II trial from China showed. Of 94 patients with locally advanced… Source link : https://www.medpagetoday.com/hematologyoncology/lungcancer/114398 Author : Publish date : 2025-02-26 22:44:22 Copyright for syndicated content belongs to the linked Source.
Author : News Health
Publish date : 2025-02-26 22:44:22
Copyright for syndicated content belongs to the linked Source.